# A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy

> **NCT02670785** · PHASE2 · COMPLETED · sponsor: **Warner Chilcott** · enrollment: 203 (actual)

## Conditions studied

- Vulvovaginal Atrophy
- Menopause
- Dyspareunia

## Interventions

- **DRUG:** Estradiol Vaginal Capsule (EVC)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02670785
- **Lead sponsor:** Warner Chilcott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-15
- **Primary completion:** 2016-11-14
- **Final completion:** 2016-11-14
- **Target enrollment:** 203 (ACTUAL)
- **Last updated:** 2017-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02670785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02670785, "A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02670785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*